Trial Profile
A study to evaluate the safety of incobotulinum toxin A (Xeomin) in children with cerebral palsy and muscle spasticity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Cerebral palsy; Muscle spasticity
- Focus Adverse reactions
- 14 Feb 2017 New trial record